Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

Summary

This is an open label study in which eligible IPF subjects who are using supplemental oxygen at rest will receive GBT440 orally daily.

Timeline

Start

2016-11

Primary completion

2017-10-23

Completion

2017-10-23

Drugs

Indications